Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study

Journal of Clinical Oncology

Volumn 20, Issue 1, 2002, Pages 42-51

  Goodwin, Pamela J ^a   Ennis, Marguerite ^a   Pritchard, Kathleen I ^a   Trudeau, Maureen E ^a   Koo, Jarley ^a   Madarnas, Yolanda ^a   Hartwick, Warren ^a   Hoffman, Barry ^a   Hood, Nicky ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GROWTH FACTOR; INSULIN; METHOTREXATE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY SIZE; BREAST CANCER; BREAST EPITHELIUM; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CORRELATION FUNCTION; DIET RESTRICTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INSULIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONTARIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0036138579     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.1.42     Document Type: Article

References (58)

1. Insulin as a growth factor
2. Insulin-like growth factors
3. Insulin action in man
4. Insulin resistance
5. Insulin receptors in breast cancer
6. Insulin receptors in breast cancer: Biological and clinical role
7. Insulin receptor expression and clinical outcome in node-negative breast cancer
8. Insulin and related factors in premenopausal breast cancer risk
9. Insulin resistance and breast-cancer risk
10. Body size and breast cancer prognosis: A critical review
11. The effect of pre-morbid height and weight on the survival of breast cancer patients
12. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer
13. Survival of breastcancer patients and body size indicators
14. Obesity as prognostic factors in breast cancer
15. Race, nutritional status, and survival from breast cancer
16. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer
17. The effect of dietary fat on breast cancer survival among Caucasian and Japanese women in Hawaii
18. Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: A population-based study
19. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival
20. Socioeconomic factors and race in breast cancer recurrence and survival
21. Serum beta-lipoprotein, serum cholesterol and Quetelet's index as predictors for survival of breast cancer patients
22. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer
23. An examination of obesity and breast cancer survival in post-menopausal women
24. The influence of obesity on the disease-free survival in primary breast cancer
25. Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project
26. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat
27. Pre-morbid body-mass-index in breast cancer: Reversed effect on survival in hormone receptor negative patients
28. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: Results from Cancer and Leukemia Group B study 8541
29. Social class and weight as prognostic factors in early breast cancer
30. A data based approach to diet questionnaire design and testing
31. A randomized trial of cyclophosphamide, epirubicin, fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, fluorouracil in premenopausal women with node-positive breast cancer
32. Postoperative chemotherapy and tamoxifen alone in the treatment of positive node breast cancer patients 50 years and older with tumours responsive to tamoxifen: Results from National Surgical Breast and Bowel Project B-16
33. Combination chemotherapy as adjuvant treatment in operable breast cancer
34. Impact of Event Scale: A measure of subjective stress
35. Body size and breast cancer prognosis: A statistical explanation of the discrepancies
36. Significance of axillary lymph node metastasis in primary breast cancer
37. Body-mass index and mortality in a prospective cohort study of U.S. adults
38. The prognostic value of insulin-like growth factor-I in breast cancer patients: Results of a follow-up study on 126 patients
39. Prognostic values of receptors for insulin-like growth factor 1, somatostatin and epidermal growth factor in human breast cancer
40. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue
41. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer
42. Increased levels of glycoproteins containing mannose 6-phosphate in human breast carcinomas
43. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: Evidence for a second mechanism of IGF-I signaling
44. Insulin receptor isoform A, a newly recognized high-affinity insulin-like growth factor II receptor in fetal and cancer cells
45. Tyrosine kinase signalling in breast cancer: Insulin-like growth factors and their receptors in breast cancer
46. Insulin receptor substrate-1 is the predominant signalling molecule activated by insulin-like growth factor-1, insulin and interleukin-4 in estrogen receptor-positive human breast cancer cells
47. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
48. Plasma insulin-like growth-factor-I (IGF-I) concentrations in human breast cancer
49. The insulin-like growth factors and breast cancer revisited
50. Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: Clinical activity and effect on insulin-like growth factor-I (IGF-I) levels
51. Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: A prospective paired cohort study
52. Tumour makers in patients with advanced breast cancer as prognosticators: A preliminary study
53. Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin
54. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women
55. Expression of insulin-like growth factor I (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosis
56. Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer
57. Insulin-like growth factor I receptors (IGF1-R) and IGF 1 in human breast tumours